Akèy › Leksemi mieloïd egi › Illinois › Decatur
Etid klinik pou Leksemi mieloïd egi nan Decatur, IL
7 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Decatur (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Ap rekriteFaz 1/2
- Research Site, Decatur
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Decatur
- Kansè Poumon ki pa ti selil14 etid
- Kansè pwostat12 etid
- Kansè poumon10 etid
- Kansè nan tete8 etid
- Kansè renn (Kasinom selil renn)7 etid
- Karsinòm selil skuamèz tèt ak kou7 etid
- Kansè vejik6 etid
- Kansè pankreyas6 etid
- Kansè kolorektal6 etid
- Melanom5 etid
- Kansè bouch5 etid
- Kansè Ipofaringe4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.